Bioassay Impurities and Quality, Biopharmaceuticals Development, R&D, AstraZeneca, Cambridge, CB21 6GP, UK.
Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK.
Adv Biol (Weinh). 2021 Jun;5(6):e2000624. doi: 10.1002/adbi.202000624. Epub 2021 May 4.
Respiratory diseases and lower respiratory tract infections are among the leading cause of death worldwide and, especially given the recent severe acute respiratory syndrome coronavirus-2 pandemic, are of high and prevalent socio-economic importance. In vitro models, which accurately represent the lung microenvironment, are of increasing significance given the ethical concerns around animal work and the lack of translation to human disease, as well as the lengthy time to market and the attrition rates associated with clinical trials. This review gives an overview of the biological and immunological components involved in regulating the respiratory epithelium system in health, disease, and infection. The evolution from 2D to 3D cell biology and to more advanced technological integrated models for studying respiratory host-pathogen interactions are reviewed and provide a reference point for understanding the in vitro modeling requirements. Finally, the current limitations and future perspectives for advancing this field are presented.
呼吸系统疾病和下呼吸道感染是全球主要的死亡原因之一,尤其是考虑到最近严重急性呼吸综合征冠状病毒 2 型的大流行,它们具有高度的社会经济重要性。鉴于动物实验的伦理问题以及向人类疾病的转化不足,体外模型越来越重要,此外,从市场开发到临床试验的淘汰率都需要很长时间。这篇综述概述了调节呼吸系统上皮系统在健康、疾病和感染中的生物学和免疫学成分。从 2D 到 3D 细胞生物学以及更先进的技术综合模型的发展,用于研究呼吸道宿主-病原体相互作用,为理解体外模型的要求提供了一个参考点。最后,提出了该领域目前的局限性和未来的展望。